BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Genetronics Biomedical (GEB) Presenting At DNA Vaccines Forum


10/19/2005 5:13:03 PM

SAN DIEGO--(BUSINESS WIRE)--March 16, 2005--Genetronics Biomedical Corporation (AMEX:GEB), a late stage developer of oncology and other therapies using electroporation to deliver drugs and nucleic acids, announced today that Iacob Mathiesen, PhD, Executive Director, Gene Delivery, will make a presentation, by invitation, at the DNA Vaccines Forum in London, England, on March 18th, 2005, at 15:05 GMT. The theme of the forum is "How to Enhance the Safety and Potency of DNA Vaccines." Dr. Mathiesen will present data supporting the safety and enhanced efficacy of electroporation to deliver DNA plasmids into skeletal muscle of large animals. "Based upon data derived from pre-clinical studies, our electroporation technology has demonstrated that, using less DNA, it can induce immune responses earlier and that are of higher magnitude and greater durability compared to DNA plasmids alone," said Avtar Dhillon, MD, Genetronics' president and CEO. "We are pleased to present these results to this forum of industry leaders in DNA vaccination."

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES